Shares of Ocular Therapeutix were up 17.43% to $7.41 on heavy trading volume early-afternoon Thursday as the Bedford, MA-based company is partnering with the Tarrytown, NY-based biotechnology company Regeneron Pharmaceuticals . Under the agreement, the companies will collaborate on the development of a sustained release formulation of aflibercept, Regeneron's retinal disease treatment.
http://ift.tt/2dMGNQS
Tarrytown News: Local news for Tarrytown, NY continually updated from thousands of sources monitored by the B Media Net.
Subscribe to:
Post Comments (Atom)
Popular Tarrytown Roundup Posts
-
... Bronx, forced service on the Hudson Line and Amtrak's Empire Line to be suspended. With no trains running between Tarrytown and Gran...
-
1) Tonight is your chance to weigh in on a very crucial topic for our Tarrytown and Sleepy Hollow public schools. UFSD Tarrytowns Board of E...
-
As the enrollment period for health insurance coverage in 2015 begins, The Business Council of Westchester invited a panel of health care ex...
-
... firefighter, fire investigator and emergency medical technician from 1977-2001: As a former fire chief in North Tarrytown, N.Y., Kosilla...
-
... to take place in the campus presentation room. Many Westchester school districts, including most recently in Tarrytown, have opted to us...
-
Feb. 28, 2014 - TARRYTOWN, N.Y. -- Hilton Worldwide has honored Celeste Reeves, Sales Office Manager at the DoubleTree by Hilton Tarrytown, ...
-
In honor of 25 years, Food Bank for Westchester saluted its board presidents at the annual Valentine's Day Wine Tasting Dinner on Friday...
-
Tarrytown Honda announces that Dwight Dachnowicz, owner of Tarrytown Honda, has finished his three-year term as Northeast Dealer Advisory Bo...
-
Born in North Tarrytown on March 15, 1989, he was the son of Brian and Geralyn Balthazard. Brian graduated from Transfiguration School and S...
-
Tarrytown resident Vic Weinstein, 75, a member of the Town of Greenburgh Planning Board, died on Thursday, Dec. 5. Weinstein was a member of...
No comments:
Post a Comment